Organ-Chips are an exciting alternative to traditional drug-testing. A team @AstraZeneca (including IMI's Dr B Ehrhardt) and @emulatebio have now paved the way for their wider use by creating a statistical best practice framework for Organ-Chip imaging. https://t.co/TX5vn7TXa1